From Goals to Action: Multisociety Guidance on Lipid Management

Guest: Ann Marie Navar, MD, PhD With LDL cholesterol goals reinstated in the 2026 American College of Cardiology and American Heart Association Guideline on the Management of Dyslipidemia, we now have a clearer framework for intensifying lipid-lowering therapy. Dr. Ann Marie Navar explains how to select nonstatin therapies based on the degree of LDL lowering needed, patient preferences, and the treatment most likely to help patients achieve their LDL goals. Dr. Navar is an Associate Professor of Cardiology at the University of Texas Southwestern Medical Center, and she served on the Guideline Writing Committee.